DMII — DRUGS MADE IN AMER ACQ II CO

As of Q2 2026, 9 SEC-registered investment managers reported holding DMII (DRUGS MADE IN AMER ACQ II CO) in their latest 13F filings, with a combined reported value of $67.85M across 6.74M shares. That is +6.8% by share count (+431.86K shares) versus the previous quarter, while reported value moved +7.8%. Ownership is concentrated: the five largest holders account for 90.5% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 3 added to existing stakes, 2 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.

DMII is classified in the Financials sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.